Current role of multiparametric magnetic resonance imaging for prostate cancer

Quantitative Imaging in Medicine and Surgery

Sylvain Favelier⁴  Romaric Loffroy⁴  Alexandre Cochet³  Morgan Moulin¹  Olivier Chevallier⁴  Pierre Pottecher⁴  Pierre-Yves Genson⁴  Gilles Crehange²  Luc Cormier¹ 

[1] Department of Urology and Andrology, LE2I UMR CNRS 6306, Arts et Métiers, University of Burgundy, François-Mitterrand Teaching Hospital, Dijon Cedex, France;;Department of Radiation Oncology,;Department of Nuclear Medicine, LE2I UMR CNRS 6306, Arts et Métiers, University of Burgundy, Georges François Leclerc Cancer Center, Dijon, France;Department of Vascular, Oncologic and Interventional Radiology,

关键词: Prostate cancer;    multiparametric-MRI;    functional imaging;    diffusion imaging;    active surveillance;   

DOI  :  10.3978/j.issn.2223-4292.2015.10.08

学科分类：外科医学

来源: AME Publications

【 摘 要 】

Multiparametric magnetic resonance imaging (mp-MRI) has shown promising results in diagnosis, localization, risk stratification and staging of clinically significant prostate cancer, and targeting or guiding prostate biopsy. mp-MRI consists of T2-weighted imaging (T2WI) combined with several functional sequences including diffusion-weighted imaging (DWI), perfusion or dynamic contrast-enhanced imaging (DCEI) and spectroscopic imaging. Recently, mp-MRI has been used to assess prostate cancer aggressiveness and to identify anteriorly located tumors before and during active surveillance. Moreover, recent studies have reported that mp-MRI is a reliable imaging modality for detecting local recurrence after radical prostatectomy or external beam radiation therapy. Because assessment on mp-MRI can be subjective, use of the newly developed standardized reporting Prostate Imaging and Reporting Archiving Data System (PI-RADS) scoring system and education of specialist radiologists are essential for accurate interpretation. This review focuses on the current place of mp-MRI in prostate cancer and its evolving role in the management of prostate cancer.

【 授权许可】

Unknown